Title:
CONDENSED RING DERIVATIVE, AND PREPARATION METHOD, INTERMEDIATE, PHARMACEUTICAL COMPOSITION AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2016/150255
Kind Code:
A1
Abstract:
Disclosed are a condensed ring derivative, and a preparation method, an intermediate, a pharmaceutical composition and a use thereof. The condensed ring derivative of the present invention has a significant inhibitive effect on URAT1, which can effectively alleviate or treat hyperuricemia and other related diseases.
Inventors:
XU ZUSHENG (CN)
ZHANG NONG (CN)
SUN QINGRUI (CN)
WU TIANZHI (CN)
ZHANG NONG (CN)
SUN QINGRUI (CN)
WU TIANZHI (CN)
Application Number:
PCT/CN2016/073043
Publication Date:
September 29, 2016
Filing Date:
February 01, 2016
Export Citation:
Assignee:
SHANGHAI YINGLI PHARM CO LTD (CN)
International Classes:
C07D217/00; A61K31/472; A61K31/517; A61P3/00; C07D231/56; C07D237/30; C07D239/78; C07D333/60; C07D405/04; C07D471/04; C07D495/04
Domestic Patent References:
| WO2014177596A1 | 2014-11-06 | |||
| WO2014079787A1 | 2014-05-30 |
Foreign References:
| CN102482220A | 2012-05-30 | |||
| US20140005221A1 | 2014-01-02 | |||
| CN101400660A | 2009-04-01 | |||
| JPH10120680A | 1998-05-12 |
Other References:
STRATFORD, E.S. ET AL.: "Alkylation of Styrylacetic Acid Systems Using Lithium Diisopropylamide-Hexamethylphosphoramide. Effect of Temperature Variation", J. ORG. CHEM., vol. 44, no. 9, 31 December 1979 (1979-12-31), pages 1571, XP055315288
See also references of EP 3275867A4
See also references of EP 3275867A4
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
上海弼兴律师事务所 (CN)
上海弼兴律师事务所 (CN)
Download PDF: